Results 151 to 160 of about 11,500 (220)

Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey. [PDF]

JAC Antimicrob Resist
Wolie ZT, Roberts JA, López-Cortés LE, Mirón-Rubio M, Pollard J, Marizan Nor AN, Abdul-Aziz MH, Jamieson C, Seaton RA, Gilchrist M, Sime FB.   +10 more
europepmc   +1 more source

Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care. [PDF]

Pharmaceutics
Lora-Escobar SJ, Herrera-Hidalgo L, Castillo-Fernández N, Palacios-Baena ZR, Luque-Márquez R, De Alarcón A, Guisado-Gil AB, Gutierrez-Gutierrez B, Navarro-Amuedo MD, Praena-Segovia J, Mejías Trueba M, Carmona-Caballero JM, Sánchez Oliva JM, Gil-Navarro MV, López-Cortés LE.   +14 more
europepmc   +1 more source

Challenges in monitoring vancomycin in outpatient parenteral antimicrobial therapy: opportunities for mitigation utilizing OSHA's framework for mitigating workplace hazards. [PDF]

Antimicrob Steward Healthc Epidemiol
Regli DC, Warner S, Wilcox E, Zimmerman J, Bittner MJ.   +4 more
europepmc   +1 more source

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy. [PDF]

Antimicrob Steward Healthc Epidemiol
Wiley MB, Bennett KK, Siegrist EA, Neely SB, Sassine J, White BP.   +5 more
europepmc   +1 more source